 |
市场调查报告书
商品编码
1411674
深部静脉疾病治疗设备市场：按类型、最终用户划分 - 2024-2030 年全球预测Deep Venous Disease Treatment Devices Market by Type (Compression Device, Peripheral Vascular Stent, Thrombectomy & Thrombolysis Device), End User (Ambulatory Surgical Centres, Hospitals & Clinics) - Global Forecast 2024-2030 |
||||||
价格
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
深部静脉疾病治疗器材市场规模预计2023年为10.9亿美元，2024年达到11.7亿美元，预计2030年将达到18.3亿美元，复合年增长率为7.64%。
深部静脉疾病治疗设备的全球市场
| 主要市场统计 | |
|---|---|
| 基准年[2023] | 10.9亿美元 |
| 预测年份 [2024] | 11.7亿美元 |
| 预测年份 [2030] | 18.3亿美元 |
| 复合年增长率（%） | 7.64% |
FPNV定位矩阵
FPNV定位矩阵对于评估深部静脉疾病治疗设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。
市场占有率分析
市场占有率分析是一种综合工具，可以对深部静脉疾病治疗设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。
该报告对以下几个方面提供了宝贵的见解：
1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。
2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。
3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。
本报告解决了以下关键问题：
1-深部静脉疾病治疗器材市场的市场规模与预测是多少？
2-在深部静脉疾病治疗设备市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？
3-深部静脉疾病治疗器材市场的技术趋势和法律规范是什么？
4-深部静脉疾病治疗设备市场主要供应商的市场占有率是多少？
5-进入深部静脉疾病治疗器材市场的合适型态和策略手段是什么？
目录
第一章 前言
第二章调查方法
第三章执行摘要
第四章市场概况
第五章市场洞察
- 市场动态
- 促进因素
- 全球深部静脉疾病发生率增加
- 提高预防设备意识
- 抑制因素
- 替代治疗方案的可用性
- 机会
- 深部静脉疾病治疗设备的持续研发活动
- 个性化血管帐篷和间歇式空气压缩装置的开发
- 任务
- 缺乏熟练的专业人员
- 促进因素
- 市场区隔分析
- 市场趋势分析
- 高通膨的累积效应
- 波特五力分析
- 价值炼和关键路径分析
- 法律规范
第六章深静脉疾病治疗设备市场：依类型
- 压缩装置
- 末梢血管支架
- 血栓切除和溶栓装置
第七章深部静脉疾病治疗设备市场：依最终使用者分类
- 门诊手术中心
- 医院和诊所
第八章北美和南美深部静脉疾病治疗设备市场
- 阿根廷
- 巴西
- 加拿大
- 墨西哥
- 美国
第九章亚太地区深部静脉疾病治疗器材市场
- 澳洲
- 中国
- 印度
- 印尼
- 日本
- 马来西亚
- 菲律宾
- 新加坡
- 韩国
- 台湾
- 泰国
- 越南
第十章欧洲、中东和非洲的深部静脉疾病治疗设备市场
- 丹麦
- 埃及
- 芬兰
- 法国
- 德国
- 以色列
- 义大利
- 荷兰
- 奈及利亚
- 挪威
- 波兰
- 卡达
- 俄罗斯
- 沙乌地阿拉伯
- 南非
- 西班牙
- 瑞典
- 瑞士
- 土耳其
- 阿拉伯聯合大公国
- 英国
第十一章竞争形势
- FPNV定位矩阵
- 市场占有率分析：依主要企业分类
- 主要企业竞争情境分析
第12章竞争产品组合
- 主要公司简介
- Abbott Laboratories
- Acandis GmbH
- Alma Lasers GMBH
- Andratec GmbH
- AngioDynamics, Inc.
- Becton, Dickinson, and Company
- Biolitec AG
- Boston Scientific Corporation
- Cardinal Health
- Imperative Care
- Innova Vascular, Inc.
- Johnson & Johnson Medical NV
- Kavya Pharma
- Koninklijke Philips NV
- Medtronic PLC
- Merit Medical Systems, Inc.
- Nipro Corporation
- Penumbra Inc.
- Stryker Corporation
- Surmodics, Inc.
- Teleflex Incorporated
- Terumo Corporation
- 主要产品系列
第十三章附录
- 讨论指南
- 关于许可证和定价
Product Code: MRR-5C6F41F5AF51
[181 Pages Report] The Deep Venous Disease Treatment Devices Market size was estimated at USD 1.09 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 7.64% to reach USD 1.83 billion by 2030.
Global Deep Venous Disease Treatment Devices Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.09 billion |
| Estimated Year [2024] | USD 1.17 billion |
| Forecast Year [2030] | USD 1.83 billion |
| CAGR (%) | 7.64% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Deep Venous Disease Treatment Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Deep Venous Disease Treatment Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Deep Venous Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Alma Lasers GMBH, Andratec GmbH, AngioDynamics, Inc., Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Cardinal Health, Imperative Care, Innova Vascular, Inc., Johnson & Johnson Medical NV, Kavya Pharma, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra Inc., Stryker Corporation, Surmodics, Inc., Teleflex Incorporated, and Terumo Corporation.
Market Segmentation & Coverage
This research report categorizes the Deep Venous Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Compression Device
- Peripheral Vascular Stent
- Thrombectomy & Thrombolysis Device
- End User
- Ambulatory Surgical Centres
- Hospitals & Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Deep Venous Disease Treatment Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Deep Venous Disease Treatment Devices Market?
3. What are the technology trends and regulatory frameworks in the Deep Venous Disease Treatment Devices Market?
4. What is the market share of the leading vendors in the Deep Venous Disease Treatment Devices Market?
5. Which modes and strategic moves are suitable for entering the Deep Venous Disease Treatment Devices Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Deep Venous Disease Treatment Devices Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing incidences of deep vein diseases across the world
- 5.1.1.2. Rising awareness about preventative devices
- 5.1.2. Restraints
- 5.1.2.1. Availability of alternative treatment options
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing research and development activities for deep vein disease devices
- 5.1.3.2. Development of personalized vascular tents and intermittent pneumatic compression devices
- 5.1.4. Challenges
- 5.1.4.1. Lack of skilled professionals
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Deep Venous Disease Treatment Devices Market, by Type
- 6.1. Introduction
- 6.2. Compression Device
- 6.3. Peripheral Vascular Stent
- 6.4. Thrombectomy & Thrombolysis Device
7. Deep Venous Disease Treatment Devices Market, by End User
- 7.1. Introduction
- 7.2. Ambulatory Surgical Centres
- 7.3. Hospitals & Clinics
8. Americas Deep Venous Disease Treatment Devices Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Deep Venous Disease Treatment Devices Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Deep Venous Disease Treatment Devices Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. Acandis GmbH
- 12.1.3. Alma Lasers GMBH
- 12.1.4. Andratec GmbH
- 12.1.5. AngioDynamics, Inc.
- 12.1.6. Becton, Dickinson, and Company
- 12.1.7. Biolitec AG
- 12.1.8. Boston Scientific Corporation
- 12.1.9. Cardinal Health
- 12.1.10. Imperative Care
- 12.1.11. Innova Vascular, Inc.
- 12.1.12. Johnson & Johnson Medical NV
- 12.1.13. Kavya Pharma
- 12.1.14. Koninklijke Philips N.V.
- 12.1.15. Medtronic PLC
- 12.1.16. Merit Medical Systems, Inc.
- 12.1.17. Nipro Corporation
- 12.1.18. Penumbra Inc.
- 12.1.19. Stryker Corporation
- 12.1.20. Surmodics, Inc.
- 12.1.21. Teleflex Incorporated
- 12.1.22. Terumo Corporation
- 12.2. Key Product Portfolio
13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
LIST OF FIGURES
- FIGURE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
- FIGURE 2. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
- FIGURE 3. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET DYNAMICS
- FIGURE 7. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 10. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 6. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COMPRESSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR STENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY THROMBECTOMY & THROMBOLYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 10. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 13. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 14. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 15. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 16. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 17. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 18. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 19. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 20. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 21. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 23. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 24. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 25. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 26. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 27. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 28. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 29. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 30. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 31. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 32. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 33. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 35. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 36. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 37. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 39. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 40. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 41. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 43. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 44. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 45. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 46. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 47. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 49. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 50. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 51. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 52. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 53. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 56. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 57. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 58. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 59. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 60. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 62. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 64. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 65. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 66. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 68. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 70. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 71. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 72. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 74. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 76. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 77. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 78. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 80. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 81. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 82. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 83. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 84. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 86. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 87. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 88. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 90. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 92. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 93. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 94. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 96. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 98. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 99. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 100. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET LICENSE & PRICING
